Pharmafile Logo
Pharmafocus logo
Advanced Search

Contract research news in brief

June 1, 2010
Research and Development CRO, NIB

Irish contract research organisation ICON plc has acquired Timaq Medical Imaging, a Swiss provider of imaging services to pharmaceutical and …

News

Novo withdraws insulins in Greece price protest

May 31, 2010
Sales and Marketing Greece, pricing

Insulin manufacturer Novo Nordisk says it will withdraw its modern insulin products from Greece in protest at a 25% price …

News

Abbott and Daiichi Sankyo acclaimed in great places to work survey

May 31, 2010
Business Services Abbott, Daiichi Sankyo

The Great Place to Work Institute has named Abbott as one of the Top 50 Best Workplaces in the UK, …

News
Fred Hassan

Fred Hassan: the master of the pharma turnaround

May 28, 2010
Sales and Marketing Schering-Plough, management

 

Feature

Inspra performs strongly in heart failure patients

May 28, 2010
Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure

Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …

News

Woolley Pau expands client services department

May 28, 2010
Medical Communications Woolley Pau, appointment, medical communications

Woolley Pau has appointed Sarah Philp as a senior account director within its client services department. She has 10 years’ …

Appointment

Napp rises in Best Companies to Work For survey

May 28, 2010
Business Services Napp, careers, recruitment

Napp Pharmaceutical Holdings has risen to position 5 in the latest Sunday Times Top 100 Best Companies to Work For, …

News

Edelman bags the FT’s Stefan Stern

May 27, 2010
Medical Communications Edelman, appointment, medical communications

PR agency Edelman has appointed Stefan Stern director of strategy.He will provide senior counsel to the agency’s clients across all …

Appointment

Pfizer R&D head exits for AstraZeneca

May 27, 2010
Research and Development AstraZeneca, Pfizer, appointment, research and development

One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …

News

Slow recovery expected for epilepsy market

May 27, 2010
Sales and Marketing Datamonitor, Keppra, UCB, epilepsy

The global market for epilepsy treatments is expected to make a slow recovery after a wave of patent expiries from …

News
Blog footer

Digital Pharma: Byte-sized roundup

May 27, 2010
Medical Communications Twitter, digi game, disease awareness campaigns, doctors.net

This week’s roundup includes the launch of Boehringer Ingelheim’s digital diabetes hub, J&J expands Twitter use, continued international expansion at …

News

Sanofi signs biomedical collaboration with MIT

May 27, 2010
Research and Development MIT, Sanofi-Aventis, academia, biomedical

Sanofi-Aventis has formed a strategic alliance with the Centre for Biodmedical Innovation  at the Massachusetts Institute of Technology. The alliance, …

News

J&J faces FDA scrutiny for another manufacturing unit

May 27, 2010
Manufacturing and Production Advanced Sterilization Products, Ethicon, J&J, JJ, McNeil, manufacturing compliance

Another Johnson & Johnson subsidiary has come under scrutiny by FDA for failing to meet quality standards in its manufacturing. …

News

Genzyme confirms details of consent decree and $175m fine

May 27, 2010
Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Lumizyme, Thyrogen, manufacturing compliance

Genzyme’s predictions on the penalties levied for the ongoing problems at its manufacturing facility in Allston Landing have been confirmed, …

News

FDA approves Genzyme’s Lumizyme

May 27, 2010
Sales and Marketing Genzyme, Lumizyme, Myozyme, Pompe disease

US biotech Genzyme is celebrating FDA approval of its late-onset treatment for Pompe disease Lumizyme. The green light to market …

News

Roche forms translational medicine research hub

May 26, 2010
Research and Development Roche, Switzerland, academic research, translational

Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …

News

NICE rejects Bayer’s liver cancer drug

May 26, 2010
Sales and Marketing NICE, Nexavar, patient access scheme

Bayer’s liver cancer drug Nexavar has been rejected by NICE after it deemed the drug too costly for a marginal …

News

Full steam ahead for NHS boards

May 26, 2010
Monitor, NHS, government

The government is setting up new NHS boards that will act independently to allocate resources and oversee the commissioning of …

News
Abbott sign

Abbott starts head-to-head MS trial

May 25, 2010
Research and Development, Sales and Marketing Abbott, Avonex, Biogen, Gilena, daclizumab

Abbott has started enrolment for a phase III trial of daclizumab, a once-monthly injection for relapsing-remitting multiple sclerosis that it …

News

European green light for Allergan’s Ozurdex

May 25, 2010
Sales and Marketing Allergan, CHMP, Ozurdex, macular oedema

European authorities have given the green light for Ozurdex, a treatment for adults with a potentially serious eye disease. Ozurdex …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026